Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

por Gremmel, Thomas, Frelinger, Andrew L., Michelson, Alan D.
Publicado 2015

Mass Cytometry Reveals Distinct Platelet Subtypes in Healthy Subjects and Novel Alterations in Surface Glycoproteins in Glanzmann Thrombasthenia

por Blair, Thomas A., Michelson, Alan D., Frelinger, Andrew L.
Publicado 2018

Novel aspects of antiplatelet therapy in cardiovascular disease

por Gremmel, Thomas, Michelson, Alan D., Frelinger, Andrew L., Bhatt, Deepak L.
Publicado 2018

P2Y(12) Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant Activity

por Berny‐Lang, Michelle A., Jakubowski, Joseph A., Sugidachi, Atsuhiro, Barnard, Marc R., Michelson, Alan D., Frelinger, Andrew L.
Publicado 2013

GLS-409, an Antagonist of Both P2Y(1) and P2Y(12), Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation

por Smolensky Koganov, Elena, Michelson, Alan D., Yanachkov, Ivan B., Yanachkova, Milka I., Wright, George E., Przyklenk, Karin, Frelinger, Andrew L.
Publicado 2018

Publisher Correction: GLS-409, an Antagonist of Both P2Y(1) and P2Y(12), Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation

por Smolensky Koganov, Elena, Michelson, Alan D., Yanachkov, Ivan B., Yanachkova, Milka I., Wright, George E., Przyklenk, Karin, Frelinger, Andrew L.
Publicado 2018

Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphology

por Frelinger, Andrew L., Gerrits, Anja J., Neculaes, V. Bogdan, Gremmel, Thomas, Torres, Andrew S., Caiafa, Anthony, Carmichael, Sabrina L., Michelson, Alan D.
Publicado 2018

Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin...

por Neculaes, Bogdan, Frelinger, Andrew L., Gerrits, Anja J., Gremmel, Thomas, Forde, Emma E., Klopman, Steven, Carmichael, Sabrina L., Michelson, Alan D.
Publicado 2021

PF‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study

por Charnigo, Robert J., Beidler, David, Rybin, Denis, Pittman, Debra D., Tan, Beesan, Howard, Jo, Michelson, Alan D., Frelinger, Andrew L., Clarke, Nicholas
Publicado 2018

Antiplatelet Activity, P2Y(1) and P2Y(12) Inhibition, and Metabolism in Plasma of Stereoisomers of Diadenosine 5′,5′″-P(1),P(4)-dithio-P(2),P(3)-chloromethylenetetraphosphate

por Chang, Hung, Yanachkov, Ivan B., Dix, Edward J., Yanachkova, Milka, Li, YouFu, Barnard, Marc R., Wright, George E., Michelson, Alan D., Frelinger, Andrew L.
Publicado 2014

The Human Endogenous Circadian System Causes Greatest Platelet Activation during the Biological Morning Independent of Behaviors

por Scheer, Frank A. J. L., Michelson, Alan D., Frelinger, Andrew L., Evoniuk, Heather, Kelly, Erin E., McCarthy, Mary, Doamekpor, Lauren A., Barnard, Marc R., Shea, Steven A.
Publicado 2011

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet T...

por Angiolillo, Dominick J., Badimon, Juan Jose, Saucedo, Jorge F., Frelinger, Andrew L., Michelson, Alan D., Jakubowski, Joseph A., Zhu, Baojin, Ojeh, Clement K., Baker, Brian A., Effron, Mark B.
Publicado 2011

Modification of Pulsed Electric Field Conditions Results in Distinct Activation Profiles of Platelet-Rich Plasma

por Frelinger, Andrew L., Gerrits, Anja J., Garner, Allen L., Torres, Andrew S., Caiafa, Antonio, Morton, Christine A., Berny-Lang, Michelle A., Carmichael, Sabrina L., Neculaes, V. Bogdan, Michelson, Alan D.
Publicado 2016

Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium

por Jain, Abhishek, van der Meer, Andries D., Papa, Anne-Laure, Barrile, Riccardo, Lai, Angela, Schlechter, Benjamin L., Otieno, Monicah A., Louden, Calvert S., Hamilton, Geraldine A., Michelson, Alan D., Frelinger, Andrew L., Ingber, Donald E.
Publicado 2016

An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension

por Hanrahan, John P., Seferovic, Jelena P., Wakefield, James D., Wilson, Phebe J., Chickering, Jennifer G., Jung, Joon, Carlson, Kenneth E., Zimmer, Daniel P., Frelinger, Andrew L., Michelson, Alan D., Morrow, Linda, Hall, Michael, Currie, Mark G., Milne, G. Todd, Profy, Albert T.
Publicado 2019

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

por Wun, Ted, Soulieres, Denis, Frelinger, Andrew L, Krishnamurti, Lakshmanan, Novelli, Enrico M, Kutlar, Abdullah, Ataga, Kenneth I, Knupp, Charles L, McMahon, Lillian E, Strouse, John J, Zhou, Chunmei, Heath, Lori E, Nwachuku, Chuke E, Jakubowski, Joseph A, Riesmeyer, Jeffrey S, Winters, Kenneth J
Publicado 2013